167
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Platelet volume as a parameter for platelet activation in patients with endometrial cancer

, , &
Pages 301-304 | Published online: 03 Apr 2013

References

  • Apte SM, Fan D, Killion JJ, Fidler IJ. 2004. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clinical Cancer Research 10:897–890.
  • Bozkurt N, Yuce K, Basaran M, Kose F, Ayhan A. 2004. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstetrics and Gynecology 103:82–85.
  • Dabrow MB, Francesco MR, McBrearty FX, Caradonna S. 1998. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecologic Oncology 71:29–37.
  • De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R, . 1999. The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. International Journal of Gynecological Cancer 9:198–205.
  • Gadducci A, Cosio S, Zola P, Tisi G, Ferrero A, Piovano E, . 2010. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study. International Journal of Gynecological Cancer 20:1399–1404.
  • Giles H, Smith REA, Martin JF. 1994. Platelet glycoprotein IIb–IIIa and size are increased in acute myocardial infarction. European Journal of Clinical Investigation 24:69–72.
  • Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, . 2009. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. Journal of Clinical Oncology 27:5794–5799.
  • Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H. 2002. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Annals of Surgical Oncology 9:287–291.
  • Iwasaki A, Hamanaka W, Harnada T, Maekawa S, Enatsu S, Shirakusa T. 2007. Significance of platelet counts in patients who underwent surgical treatment for lung metastasis. International Surgery 92: 103–109.
  • Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. 1983. Arachidonic acid metabolism by platelets of differing size. British Journal of Haematology 53:503–511.
  • Khan FA, Shukla AN, Joshi SC. 2008. Anaemia and cancer treatment: a conceptual change. Singapore Medical Journal 49:759–764.
  • Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J . 2006. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proceedings of the National Academy of Sciences USA 103:855–860.
  • Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. 2007. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecologic Oncology 104:91–104.
  • Li AJ, Madden CM, Cass I, Leuchter RS, Lagasse LD. 2004. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecologic Oncology 92:211–214.
  • Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. 2010. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. Journal of Thrombosis and Thrombolysis 30:251–262.
  • Metindir J, Bilir Dilek G. 2009. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. Journal of Cancer Research and Clinical Oncology 135:125–129.
  • Scholz HS, Petru E, Gucer F, Haas J. 2000. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Research 20:3983–3985.
  • Sierko E, Wojtukiewicz MZ. 2004. Platelets and angiogenesis in malignancy. Seminars in Thrombosis and Hemostasis 30:95–108.
  • Suzuki K, Aiura K, Kitagou M, Hoshimoto S, Takahashi S, Ueda M, . 2004. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepato-Gastroenterology 51:847–853.
  • Tamussino KF, Gucer F, Reich O, Moser F, Petru E. 2001. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. International Journal of Gynecological Cancer 11:236–240.
  • Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. 1983. Platelet size as a determinant of platelet function. Journal of Laboratory and Clinical Medicine 101:205–213.
  • Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. 1984. Platelet size and age determine platelet function independently. Blood 63:1372–1375.
  • Threatte GA. 1993. Usefulness of the mean platelet volume. Clinics in Laboratory Medicine 13:937–950.
  • Tschoepe D, Roesen P, Kaufmann L, Schauseil S, Kehrel B, Ostermann H . 1990. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. European Journal of Clinical Investigation 20:166–170.
  • Varlotto J, Stevenson MA. 2005. Anemia, tumor hypoxemia, and the cancer patient. International Journal of Radiation Oncology, Biology, Physics 63:25–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.